MIRM - Mirum Pharmaceuticals Inc. (MIRM) Q1 2024 Earnings Call Transcript

2024-05-11 14:25:17 ET

Mirum Pharmaceuticals, Inc. (MIRM)

Q1 2024 Earnings Conference Call

May 08, 2024, 04:30 PM ET

Company Participants

Andrew McKibben - Vice President, Investor Relations

Chris Peetz - Chief Executive Officer

Peter Radovich - President & Chief Operating Officer

Joanne Quan - Chief Medical Officer

Eric Bjerkholt - Chief Financial Officer

Conference Call Participants

Jessica Fye - JPMorgan

Mani Foroohar - Leerink Partners

Gavin Clark-Gartner - Evercore ISI

Dae Gon Ha - Stifel

Steven Seedhouse - Raymond James

David Lebowitz - Citi

Jon Wolleben - Citizens JMP

Thomas Yip - H.C. Wainwright

Presentation

Operator

Hello, and welcome to the Mirum Pharmaceuticals First Quarter 2024 Financial Results and Business Update. My name is Terry, and I will be the conference operator today. All lines have been placed on mute to prevent any background noise. [Operator Instructions]

I will now hand the call over to Andrew McKibben, Vice President of Investor Relations, to begin. Please go ahead.

Andrew McKibben

Thanks, Terry, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals first quarter 2024 conference call.

I'm joined today by our CEO, Chris Peetz; our President and Chief Operating Officer, Peter Radovich; Chief Medical Officer, Joanne Quan; and Eric Bjerkholt, our Chief Financial Officer.

Earlier today, Mirum issued a news release announcing the company's results for the first quarter 2024. Copies of this news release and SEC filings can be found in the Investors section of our website....

For further details see: